United States · Biotechnology startup
United States · Mirum Pharmaceuticals
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Funding reportedLast round: Post-IPO Debt
Follow Mirum Pharmaceuticals and see its new rounds in your feed.Start following
What company datasets say Mirum Pharmaceuticals raised
Funding, as reported
Reported in all$600Min dollars
Last roundPost-IPO Debt
Investors listed5
SEC Form D$139M sold, 3 filings, last Jan 2026
Founders and team
From Mirum Pharmaceuticals's own website: 10 on the team.
- Chris PeetzChief Executive Officer
- Peter RadovichPresident & Chief Operating Officer
- Michael EhrmanExecutive Vice President & General Manager, North America
- Doug SheehyChief Legal Officer & Secretary
- Eric BjerkholtChief Financial Officer
- Erin CampanyChief People Officer
- Lara LongpreChief Development Officer
- Laura BregeBoard Member
- Mike GreyChairman of the Board, Mirum Pharmaceuticals
- William C. FaireyBoard Member
On 3 portfolio pages
Investors who name them
Each firm lists Mirum Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Mirum Pharmaceuticals in front of investors. Or tell us what we have wrong.